The cholesterol-lowering drug bempedoic acid reduced the combined rate of major adverse cardiovascular events by 13%, meeting its primary endpoint in a large study of patients with high cholesterol who were unable to tolerate ...
Mar 6, 2023
0
36
When older adults with cancer take multiple medications—including ordinary drugs like blood pressure pills, supplements, or antacids—it can result in more toxic chemotherapy side effects and even a need to stop cancer ...
Feb 27, 2023
0
3
An analysis of 144 pivotal trials for U.S. Food and Drug Administration (FDA)-approved medications in cancer, cardiovascular disease, and neurology has found that more than half of the studies recruit patients from low- and ...
Nov 22, 2022
0
4
A systematic review of patient-reported outcome measures (PROMs) used in cardiovascular disease (CVD) populations has found that most fall short of quality standards required to guide clinical research and practice. Few measurements ...
Sep 20, 2022
0
0
Adults with ADHD are at greater risk of developing a range of cardiovascular diseases than those without the condition, according to a large observational study led by researchers at Karolinska Institutet and Örebro University. ...
Sep 15, 2022
0
43
Brief exposure to direct-to-consumer advertising (DTCA) has a large and positive association with medication-related demand intentions, according to a study published online Aug. 12 in JAMA Health Forum.
Aug 12, 2022
0
3
A visit to the dentist's office could provide a glimpse into your heart and brain health.
Aug 11, 2022
0
4
Sodium–glucose cotransporter 2 (SGLT2) inhibitors, such as empagliflozin, dapagliflozin, canagliflozin and ertugliflozin, have been game changers in the treatment of type 2 diabetes, but their potential for closing the ...
Jul 25, 2022
0
28
Drugs don't always behave exactly as expected. While researchers may develop a drug to perform one specific function that's perhaps tailored to work for a specific genetic profile, sometimes the drug might perform several ...
Jul 12, 2022
0
4
A drug recently approved to treat type 2 diabetes is also extremely effective at reducing obesity, according to a new study.
Jun 6, 2022
0
181
